Vascular Grafts - Medical Devices Pipeline Assessment, 2015
Summary
GlobalDatas Medical Devices sector report, Vascular Grafts - Medical Devices Pipeline Assessment, 2015 provides an overview of Vascular Grafts currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vascular Grafts Overview 7
3 Products under Development 8
3.1 Vascular Grafts - Pipeline Products by Stage of Development 8
3.2 Vascular Grafts - Pipeline Products by Territory 9
3.3 Vascular Grafts - Pipeline Products by Regulatory Path 10
3.4 Vascular Grafts - Pipeline Products by Estimated Approval Date 11
3.5 Vascular Grafts - Ongoing Clinical Trials 12
4 Vascular Grafts - Pipeline Products under Development by Companies 13
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 13
4.2 Vascular Grafts - Pipeline Products by Stage of Development 14
5 Vascular Grafts Companies and Product Overview 15
5.1 3S BioMedical, Inc. Company Overview 15
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Anethon (Inactive) Company Overview 17
5.2.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 ARISTE Medical Company Overview 18
5.3.1 ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Cardiojustable LLC Company Overview 20
5.4.1 Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 CryoLife, Inc. Company Overview 21
5.5.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 DSM Biomedical B.V. Company Overview 23
5.6.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Eqalix, Inc. Company Overview 24
5.7.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 FIT Biotech Oy Company Overview 26
5.8.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Gel-Del Technologies, Inc. Company Overview 28
5.9.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 Graftworx, LLC Company Overview 29
5.10.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Healionics Corporation Company Overview 30
5.11.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 Innovia LLC Company Overview 31
5.12.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 MultiGene Vascular Systems (MGVS) Ltd. Company Overview 32
5.13.1 MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 NuVascular Technologies Inc Company Overview 34
5.14.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 35
5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35
5.16 SurgaColl Technologies Ltd Company Overview 36
5.16.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.17 Universidad de Los Andes Company Overview 37
5.17.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 37
5.18 VesselTek BioMedical LLC Company Overview 38
5.18.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.19 Xeltis AG Company Overview 41
5.19.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 41
6 Vascular Grafts- Recent Developments 44
7 Appendix 46
7.1 Methodology 46
7.2 About GlobalData 48
7.3 Contact Us 49
7.4 Disclaimer 49
List Of Tables
1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Table 2: Vascular Grafts - Pipeline Products by Territory 9
Table 3: Vascular Grafts - Pipeline Products by Regulatory Path 10
Table 4: Vascular Grafts - Pipeline Products by Estimated Approval Date 11
Table 5: Vascular Grafts - Ongoing Clinical Trials 12
Table 6: Vascular Grafts Companies - Pipeline Products by Stage of Development 13
Table 7: Vascular Grafts - Pipeline Products by Stage of Development 14
Table 8: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status 15
Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description 15
Table 11: Resorpor AdvaMatrixrPro Vessel Graft - Product Status 16
Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Description 16
Table 13: Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17
Table 14: Anethon Blood Vessel - Product Status 17
Table 15: Anethon Blood Vessel - Product Description 17
Table 16: ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 18
Table 17: Drug Eluting Vascular Graft - Product Status 19
Table 18: Drug Eluting Vascular Graft - Product Description 19
Table 19: Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: Adjustable Vascular Graft - Product Status 20
Table 21: Adjustable Vascular Graft - Product Description 20
Table 22: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: Synergraft Xenograft Vascular Graft - Product Status 22
Table 24: Synergraft Xenograft Vascular Graft - Product Description 22
Table 25: DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: Small Diameter Vascular Graft - Product Status 23
Table 27: Small Diameter Vascular Graft - Product Description 23
Table 28: Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 29: CardioVessel - Product Status 24
Table 30: CardioVessel - Product Description 24
Table 31: LCL Graft - Product Status 25
Table 32: LCL Graft - Product Description 25
Table 33: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: GTU X-Graft - Product Status 26
Table 35: GTU X-Graft - Product Description 26
Table 36: GTU X2-Graft - Product Status 27
Table 37: GTU X2-Graft - Product Description 27
Table 38: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 39: VasoGraft - Product Status 28
Table 40: VasoGraft - Product Description 28
Table 41: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: Smart Graft - Product Status 29
Table 43: Smart Graft - Product Description 29
Table 44: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: STARgraft - Vascular Reconstruction - Product Status 30
Table 46: STARgraft - Vascular Reconstruction - Product Description 30
Table 47: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
Table 48: 4mm Vascular Graft - Product Status 31
Table 49: 4mm Vascular Graft - Product Description 31
Table 50: MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: MultiGeneGraft - Product Status 33
Table 52: MultiGeneGraft - Product Description 33
Table 53: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 54: BioFunc - APC Vascular Graft - Product Status 34
Table 55: BioFunc - APC Vascular Graft - Product Description 34
Table 56: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35
Table 57: Enhanced Vascular Graft - Product Status 35
Table 58: Enhanced Vascular Graft - Product Description 35
Table 59: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: CardioColl - Product Status 36
Table 61: CardioColl - Product Description 36
Table 62: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: SiSgraft - Product Status 37
Table 64: SiSgraft - Product Description 37
Table 65: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: VTek Graft - Product Status 38
Table 67: VTek Graft - Product Description 38
Table 68: VTek-RA Graft - Product Status 39
Table 69: VTek-RA Graft - Product Description 39
Table 70: VTek-RA Wrap - Product Status 40
Table 71: VTek-RA Wrap - Product Description 40
Table 72: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 41
Table 73: Endogenous Tissue Growth Implant - Product Status 41
Table 74: Endogenous Tissue Growth Implant - Product Description 41
Table 75: Xeltis AG - Ongoing Clinical Trials Overview 42
Table 76: Endogenous Tissue Growth Implant - Initial Safety and Performance of the COR-VP-001 Vascular Patch in Pediatric Patients Undergoing the Right Ventricular Outflow Tract (RVOT) Reconstruction 43
Table 77: Glossary 47
List Of Figures
1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Figure 2: Vascular Grafts - Pipeline Products by Territory 9
Figure 3: Vascular Grafts - Pipeline Products by Regulatory Path 10
Figure 4: Vascular Grafts - Pipeline Products by Estimated Approval Date 11
Figure 5: Vascular Grafts - Ongoing Clinical Trials 12
